Singleton Mark Leonard bought BVS

March 15, 2024 · Form 4 insider transaction

Singleton Mark Leonard bought 42,202 shares of Bioventus Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.

Direction
Acquired (buy-side)
Shares
42,202
Price
$0.00
Total value
N/A
Role
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 15, 2024
Filing dateMarch 22, 2024
Shares owned after42,202
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.; The RSUs shall vest on June 15, 2024, subject to the Reporting Person continuing in service through the applicable vesting date.

View the original Form 4 on SEC EDGAR